Valproate therapy and nonalcoholic fatty
โ
Gerhard J. Luef; Markus Waldmann; Wolfgang Sturm; Anis Naser; Eugen Trinka; Iris
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 77 KB
๐ 1 views
## Abstract Nonalcoholic fatty liver disease was defined recently as another symptom of insulin resistance. Continuous therapy with valproate can result in increased body weight and insulin resistance, but no data are yet available on a possible relationship between valproate and nonalcoholic fatty